Marquard - Ruhr University BochumParkinson's diseasebetaSense GmbH identifies new diagnostic b...A new biomarker for Parkinson’s disease makes it possible to recognise and treat the hereditary dopamine deficiency before the mid-brain is damaged, reports University Bochum spin-out betaSense GmbH … more ➔
adobe stock - Yanina FinancingOryzon cashes in €30mBarcelona-based epigentics specialist Oryzon Genomics, SA, a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today the successful completion has completed an … more ➔
Cytovation ASAFinancingCytovation ASA bags additional US$6m to dr...Cytovation ASA has baged US$6m to advance Phase II development of its bi-specific pore-forming peptide candidate CY-101 in patients with adrenocortical carcinoma. more ➔
TraderfoxM&AKKR makes US$1.22bn tender for Swedish Bio...RWK Bidco AB, newly founded by the private equity firm KKR (Kohlberg Kravis Roberts & Co.), has identified Swedish separation specialist Biotage AB as a takeover target and submitted an official takeover … more ➔
adobe stock - JHVEPhoto PartnershipBoehringer Ingelheim inks deal with Tessal...Boehringer Ingelheim and synthetic lethality specialist Tessellate Bio have entered into an €500m biobucks global license agreement on oral first-in-class cancer treatments. more ➔
adobe stock - peterschreiber.media US tariff policy Roche and Novartis react to US tariffsDespite the World Trade Organisation’s (WTO) ban of tariffs on pharmaceuticals, US President Donald Trump has announced he would consider imposing tariffs on pharmaceutical products. In a fast reaction, … more ➔
Image by freepikDairy alternativesWhey Waste Finds New Life as ProteinFrench dairy heavyweight Bel Group has teamed up with Standing Ovation in a bid to transform surplus whey from cheese production into high-value casein proteins using precision fermentation. The collaboration … more ➔
uniqure NVGene TherapyAMT-130 gets FDA breakthrough therapy desi...Amsterdam-based uniQure NV’s gene therapy candidate AMT-130 has been granted FDA Breakthrough Therapy Designation for the treatment of the neurodegenerative Huntington’s disease. more ➔
RijksoverheidGovernanceNetherlands Sets Sights on Global Biotech...The Netherlands has set itself an ambitious goal: to be among the global leaders in biotechnology by 2040. This vision is backed by an initial commitment of €1.3 billion in funding. more ➔
123rf.com/guniitaNeurodegenerative DisordersNLS and Kadimastem: Swiss-israeli merger i...NLS Pharmaceutics secures US$2m equity funding and signs US$25m equity facility to support merger with Kadimastem (Israel) to combine expertise in aiming to become a leader in regenerative medicine in … more ➔
Marquard - Ruhr University Bochum
adobe stock - Yanina 
Cytovation ASA
Traderfox
adobe stock - JHVEPhoto 
adobe stock - peterschreiber.media 
uniqure NV
Rijksoverheid
123rf.com/guniita